Recent Finacing
Recent Raise
Axelyf develops lipid nanoparticle delivery systems and ionizable lipid libraries for RNA therapeutics, using surface chemistry and ANNA machine-learning optimization to enable extrahepatic and liver-directed delivery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Axelyf.